DJIA 17,730.11 -27.80 -0.16%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 -0.64 -0.03%
market minute promo

MannKind Corp (NASDAQ: MNKD)

5.32 -0.26 (-4.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNKD $5.32 -4.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.55
Previous Close $5.58
Daily Range $5.25 - $5.58
52-Week Range $3.46 - $10.26
Market Cap $2.2B
P/E Ratio -11.82
Dividend (Yield) $0.00 (0.0%)
Volume 7,320,457
Average Daily Volume 9,432,798
Current FY EPS -$0.31

Sector

Healthcare

Industry

Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary Rss Feed

3 Biotech Stocks with Low Liquidity Ratios -- Are They in Trouble?

Do low liquidity ratios point to danger ahead for these biotech stocks?

PSA: Afrezza Is NOT Exubera

Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point

Interesting MNKD Put And Call Options For August 14th

What A MannKind Investor Needs To Know

MannKind's Afrezza Lags Behind Biggest Failure in Inhaled Insulin

MNKD Crosses Below Key Moving Average Level

Why Current Prescription Numbers For Afrezza Don't Matter

Wall Street is Betting Big Against These 3 Biotechs

Biotech stocks have had a huge run recently, and now Wall Street is betting heavily against these 3 recent winners.

MannKind's Afrezza: Another Look At The Early Adopters

See More MNKD News...

MNKD's Top Competitors

MNKD $5.32 (-4.57%)
Current stock: MNKD
AMGN $153.26 (-1.12%)
Current stock: AMGN
GILD $115.04 (-0.84%)
Current stock: GILD
BIIB $404.28 (-0.28%)
Current stock: BIIB